Detection Algorithms · Detection algorithms are designed to accurately detect cardiac signals,...
Transcript of Detection Algorithms · Detection algorithms are designed to accurately detect cardiac signals,...
Mule 1Rhythm Detection / Therapy Delivery
Detection Algorithms
EMBLEMTM/ EMBLEMTM MRI S-ICD SystemAdvanced Physician Training
CRM-349608-AB JULY2016
Index
Learning Objectives
Detection Algorithms
Phases of Operation
Detection Phase
Signal Filters
DetectionProfiles
Certification Phase
DetectionCertification
RateCertification
Decision Phase
Rate Analysis
ArrhythmiaClassification
Therapy Decision
Software Updates
SMART Pass Technology
AF Monitor
Reference
Rhythm Discrimination Examples
Algorithm Architecture
Brief Summary: EMBLEMTM MRI S-ICD
Detection Algorithms l Page 1
Detection Algorithms
CRM-349608-AB JULY2016
Detection Algorithms Learning Objectives
After completing this module, you should be able to:
•DescribetheprocessusedbytheEMBLEMTM S-ICD System tofilternon-cardiacS-ECGsignals.
• ExplainhowtheEMBLEM S-ICD System transitions betweendetectionprofilesastheheartratechanges.
•DescribehowtheEMBLEM S-ICD Systemcertifiestheaccuracyofheartratecalculations.
• Describethearrhythmiaanalysisstrategiesused by the EMBLEM S-ICD System to classify arrhythmiadetections.
• Describethetherapydecisionstrategyusedbythe EMBLEM S-ICD Systemtoconfirmtheneedforshocktherapy.
• DescribehowtheSMARTPassfilterreducesT-waveoversensing.
• ExplainhowtheAFMonitorhelpsdetectsilentornewonsetAFandAFprogression.
Detection Algorithms l Page 2
CRM-349608-AB JULY2016
Phases of Operation
Detection algorithms are designed to accurately detect cardiac signals, ensure the detection is cardiac in nature,anddecideiftherapyiswarranted.
•Duringthedetection phase, thesystemfilters(removes) non-cardiac signals and uses rate detectionprofilestosenselikelycardiacactivations.
• Duringthecertification phase, the system confirmsthecardiacnatureofsensedactivationsand uses several algorithms to identify and correct oversensing, thereby ensuring the accuracy of heart ratecalculations.
• Duringthedecision phase, the system analyzes thecertifiedheartrateandclassifiesdetectionstodetermineifthereisashockablearrhythmia.Detections within the Conditional Shock Zone (dual zone programming) are analyzed via the three rhythm discrimination algorithms.
Theamplitudeofasubcutaneoussignal(S-ECG)issmallerthanthatofatransvenoussignal(TV-ECG)andthefrequencycontentdifferssignificantly.Theextrastepofcertificationpreventscountingofnon-cardiacsignals.
Detection algorithms are designed to accurately detect cardiac signals, ensure the detection is cardiac in nature, and decide if therapy is required.
During Automatic Setup, the system stores the patient’s NSR template for reference during arrhythmiaanalysis.
KEY CONCEPT
NOTES
Detection Algorithms
Detection Algorithms l Page 3
Discrimination Algorithms
CRM-349608-AB JULY2016
Signal Filters
Band Pass and Notch filters permit cardiac signals to passthroughforanalysis.
•TheBand Pass filter acceptsS-ECGsignalswithinthe cardiac frequency range and rejects signals outsidethatrange.
• TheNotch filter removespowerlinefrequencies.Thisfilterisautomaticallyconfiguredduringinitialprogramming upon selection of the Time Zone (geographicregion).InNorthAmericathesettingis60Hz;inEuropeitis50Hz.SeeFigureB.
SignalfiltersrejectS-ECGsignalsoutside the cardiac frequency range.
The programmer prompts the user to reset the Time Zone after a batterycharge.
Figure A: Signal filters Figure B: Notch filter settings
KEY CONCEPT
NOTES
Detection Phase
Detection Algorithms l Page 4
CRM-349608-AB JULY2016
Detection Profiles
The EMBLEMTMS-ICDSystemtransitionsbetweendetection profilesastheheartratechanges.Dual zone programming reduces the chance of inappropriate shock (IDE Study).
• The faster the detected heart rate, the more aggressive the detection profile.
• Detection sensitivity can be adjusted by programminghigherorlowerratesfortheShock Zone (170-250 bpm) and Conditional Shock Zone (170to240bpm).
With dual zone programming, the EMBLEM S-ICD System transitions betweendetectionprofiles.
Dual zone programming
KEY CONCEPT
NOTES
Detection Phase
Detection Algorithms l Page 5
Detection profiles
CRM-349608-AB JULY2016
Detection Certification
The Waveform Appraisal algorithm ensures noise detectionsarenotincludedinheartratecalculations.
•DuringWaveformAppraisal,theEMBLEMS-ICDSystem analyzes the characteristics of the detected signal.Ifnoiseissuspected,theS-ECGismarkedwithanN(noise)andtheintervalsbeforeandaftertheNarenotusedtocalculatetheheartrate.SeeFigureA.
•Example:InFigureB,theyellowdotsrepresentnoise superimposedontheNSR.Thegreendotsrepresent the certified rate. The blackdotsshowthatnoisedetectionsdonotalterthecertifiedrate.Essentially, the system cannot detect and treat arrhythmias when noise is present.
The Waveform Appraisal algorithm ensures noise detections are not includedinheartratecalculations.
Attheonemonthfollow-up,consider asking the patient to perform isometric exercises (palm press, chair raise) to assess myopotentialsensing.IftheS-ECGshowsnoisemarkers(N),evaluateothersensevectors.
Figure A: Detections Figure B: Certified Rate
KEY CONCEPT
NOTES
Certification Phase
Detection Algorithms l Page 6
S = certified detection N = suspect detection
CRM-349608-AB JULY2016
Rate Certification
Rate Certification algorithms ensure double detections arenotincludedinheartratecalculations.
•Algorithm1:Static Template Analysis identifiesandcorrectsT-wavedoubledetection(alternatingmorphologypattern).Itcomparesthemorphologyof the stored NSR template to that of the last three intervals and looks for a match-nonmatch-match pattern.
•Algorithm2:Wide Complex Analysis identifiesandcorrectsdoubledetectionofwidemorphologycomplexes,whichmayoccurwithbundlebranchblock.Itlooksforarepeatingpatternofcloselycoupleddetectionsandappliesvariouscriteria.
•Algorithm3:Interval Analysis identifiesdoubledetections(widecomplexorT-wave)bylookingforapatternofalternatingintervaldurations(e.g.,long-short,long-short).
•Algorithm4: Alternating Morphology Analysis identifiesan alternating morphology pattern in a group of three successive complexes (match-nonmatch-matchpattern).It uses the stored template for width.
Overcounteddetectionsaremarkedwithadotanddiscarded.Validintervalsarecombinedintoonecertifiedinterval.
StaticTemplateAnalysisidentifiesandcorrectsT-wavedoubledetectionbasedonthestoredNSRtemplate.
WideComplexAnalysisidentifiesandcorrectsdoubledetectionofwidemorphologycomplexes.
Interval Analysis corrects oversensing by identifyingalternatingintervaldurations.
Alternating Morphology Analysis identifiesanalternatingmorphologypattern in a group of three successive complexes..
The EMBLEMTM S-ICD System manages oversensing via pre-implant patient screening, post-implant template formation, and rate certificationalgorithms.
KEY CONCEPT
NOTES
Certification Phase
Detection Algorithms l Page 7
Algorithm 1: Static Template Analysis
Algorithm 4: Alternating Morphology Analysis Algorithm 3: Interval Analysis
Algorithm 2: Wide Complex Analysis
CRM-349608-AB JULY2016
Rate Analysis
Uponcertification,theEMBLEMTM S-ICD System decides if the detection falls into a non-shockable zone (NSR Mode)ortherapyzone(TachyMode).
•ThesystemtransitionsfromNSR Mode to Tachy Modewhenthecertifiedheartratereachesthelowest programmed therapyzone.
•ThesystemtransitionsfromTachy Mode to NSR Mode whentheheartrateremainsbelowthethe Hysteresis Zone (40 ms) for 24 consecutive intervals.This prevents a premature return to NSR Mode in the event of underdetection.
TachyModestartswhentheheartratereachesthelowestprogrammed therapy zone and endswhentherateismaintainedbelowtheHysteresisZonefor24intervals.
KEY CONCEPT
NOTES
Decision Phase
Detection Algorithms l Page 8
CRM-349608-AB JULY2016
Arrhythmia Classification
The Arrhythmia Classification diagram showshowthe EMBLEMTMS-ICDSystemdecidesifthecertifieddetection is a normal sensed beat (S) or ventricular tachycardia(T)requiringshocktherapy.
•AllcertifieddetectionswithintheprogrammedShockZoneareconsideredshockable.
•AllcertifieddetectionswithintheConditionalShockZone are analyzed via the rhythm discrimination algorithmsasfollows:- Static Morphology compares the degree of morphologysimilaritybetweenthecurrentdetectionandthestoredNSRtemplate.
- Dynamic Morphology compares the degree of morphologysimilaritybetweentwoconsecutivedetections.
- QRS Width comparestheQRSwidthofthecurrentdetectionwiththestoredNSRtemplate.AmonomorphicarrhythmiawithawideQRSisconsideredshockable(T).OnewithanarrowQRSisconsiderednormal(S).
ArrhythmiaClassificationisusedtoidentify VT/VF episodes that require shocktherapy.
It is important to store an NSR template to ensure optimal applicationofalgorithms.
KEY CONCEPT
NOTES
Decision Phase
Detection Algorithms l Page 9
CRM-349608-AB JULY2016
Therapy Decision
After identifying shockable VT/VF episodes, the EMBLEMTM S-ICD System performs several therapy decisionstepstoconfirmthepatient’sneedforshocktherapy.
•ThesystemevaluatesX/Y criteria to ensure the VT/VFepisodeissustained.X/Yisacounterthatcompares detections and compensates for double detectionsandnoise.
• SMART Charge ensurestheVT/VFepisode(X/Ycount) is sustained for a sufficient duration before charging. The nominal duration before charging is twoadditionalintervalsafterx/ycriteriaaremet(e.g.18/24).Thesystemautomaticallyextendstheduration in the presence of a non-sustained VT/VF (uptofiveextensionsandfifteenintervals).
• Charge Confirmationensuresthetwomostrecentdetections remain shockable before initiating the capacitor charge.
• Shock Confirmation ensures the VT/VF episode is still present after capacitor charging is complete. This strategy prevents unnecessary therapy for short VT runs after spontaneous VT/VF termination.
Uponshockconfirmation,theEMBLEMS-ICDSystemdeliversashocksynchronizedtothenextdetection.
Therapy Decision algorithms confirmtheneedforshocktherapy.
KEY CONCEPT
NOTES
Decision Phase
Detection Algorithms l Page 10
CRM-349608-AB JULY2016
SMART Pass TechnologySoftware Updates
SMART Pass isathirdgenerationsoftwareupdatethat reduces the incidence of cardiac oversensing by applyinganadditionalHighPassfilter.
•SMARTPassreducestheamplitudeoflowfrequencysignalssuchasT-waves.ItallowshighfrequencysignalssuchasR-waves,VT,andVFtopassthrough.FigureA.
•WhenSMARTPassisOn,theEMBLEMS-ICDusestheRateCertificationalgorithmstocalculatetheheartrateasusual.Certifieddetectionsareanalyzed via the rhythm discrimination algorithms asusual.
•FigureBcomparessensingwithSMARTPassOFFandOn.WhenprogrammedOn,lowamplitudeT-wavesignalsarefilteredout.
EFFORTLESSstudyresultsatthreeyearsshowedthatS-ICDsoftwareupdatesreducedtheincidenceofinappropriateshockfrom8.1%to3.8%.1 FigureC.
Figure C: Projected effect of S-ICD detection software updates
KEY CONCEPT
NOTES
SMART Pass reduces the amplitude oflowfrequencysignals(T-waves)to reduce cardiac oversensing and inappropriateshock.
Detection Algorithms l Page 11
Figure A: SMART Pass Technology Figure B: SMART Pass Off vs On
Use Manual Setup to update theEMBLEMS-ICDsoftware(SeeIFU).Storeanexercisetest template to ensure optimal applicationofSMARTPass.
CRM-349608-AB JULY2016
AF Monitor Software Updates
The AF Monitor notifiesclinicianswhenatleastsixminutesofAFhaveaccumulatedin24hours.ItisatooltohelpindiagnosingsilentornewonsetAFanditsprogression.
•TheAFMonitorusesa192beatwindowtoanalyzeandclassifythedetectedrhythm(NSRorAF).TobeclassifiedAF,atleast60%ofthebeatsinthewindowmustbeAF.TheS-ICDaddsthedurationsofallwindowsthatmeetAFcriteriatodeterminehowmanyminutesofAFaccumulatedin24hours.
•Allwindowsareanalyzedviatwoalgorithms.TheVentricular Scatter algorithm calculates beat-to-beat rate differences to determine if the rate is stable (NSR), unstable (AF), or random (PVC, double detection).Itclassifiestherhythmbasedontheratioofeventsineachratebin.*SeeFigureA.
• TheHeart Rate Density Index (HRDI) places each of the 192 beats in a histogram depicting the heartratedistribution.ItthendeterminestheHRDIandHeartRatemodeandclassifiestherhythmasNSR(narrowdistribution,slowerrate)orAF(widerdistribution,fasterrate).SeeFigureA.
Collected AF Monitor data (number of days; number of minutes per day) can be accessed from the programmer for90daysandfromLatitudeNXTfor100days. *Astablerhythmvaries less than 5 bpm from beat to beat.Anunstablerhythmvaries morethan5bpm.
KEY CONCEPT
NOTES
The AF Monitor uses a 192 beat windowandtwoalgorithmstodeterminehowmanyminutesofAFaccumulatedin24hours.
Detection Algorithms l Page 12
Thedurationofa192beatwindowisaboutthreeminutesat60bpm.
When programmed On, the AF MonitoroperatesevenwhentachytherapyisprogrammedOff.
BenchtestingshowedthattheAFMonitorhasasensitivity≥87%andapositivepredictivevalue≥90%.2
Figure A: AF algorithms: Ventricular Scatter, Heart Rate Density Index (HRDI)
CRM-349608-AB JULY2016
Discrimination ExampleReference
NSR to shockable polymorphic VT
•Static morphology (red): decreased correlation to NSR template
•Dynamic morphology (green): beat-to-beat dissimilarity
•QRSwidth(pink):widerthanNSR
KEY CONCEPT
NOTES
NSR to shockable polymorphic VT
Detection Algorithms l Page 13
CRM-349608-AB JULY2016
Discrimination Example Reference
NSR to monomorphic VT
•Static morphology (red): decreased correlation to NSR template
•Dynamic morphology (green): beat-to-beat similarity
•QRSwidth(notshown):IfQRSwidenscomparedtoNSR, shock therapy is required
KEY CONCEPT
NOTES
NSR to monomorphic VT
Detection Algorithms l Page 14
CRM-349608-AB JULY2016
Discrimination ExampleReference
NSR to shockable VT
•Static morphology (red): drops during VT
• Dynamic morphology (green): remains high during beat-to-beat
•QRSwidth(pink):isnarrowduringNSRandwideduring VT
KEY CONCEPT
NOTES
NSR to shockable VT
Detection Algorithms l Page 15
CRM-349608-AB JULY2016
Algorithm Architecture Summary
Summary of arrhythmia evaluation:
•Detection Phase The EMBLEMTM S-ICD System filters(removes)non-cardiacsignalsandusesrate-dependentdetectionprofilestosenselikelycardiacactivations.
• Certification Phase The EMBLEM S-ICD System certifiesdetectionsviaWaveformAppraisal;thencertifiestheheartrateviaoversensingalgorithms.
•Decision Phase The EMBLEM S-ICD System analyzes the rate to identify possible tachyarrhythmias; then analyzes subsequent detections using discrimination algorithmsandX/Ycriteriatodecideiftherapyisnecessary.
Phases of arrhythmia detection1.Detectcardiacsignals2.Certifydetections3.Decideiftherapyisneeded
KEY CONCEPT
NOTES
Reference
Detection Algorithms l Page 14
The discrimination algorithms apply only to the Conditional Shock Zone (dual zone programming).
CRM-349608-AB JULY2016
References
1.TheunsD,etal.EvaluationofanovelalgorithmdesignedtoreduceoversensingintheS-ICD.HRS.2016:AB05-01.
2.EMBLEMS-ICD,EMBLEMS-ICDUsersManual.359480-001EN.US2015:11.
Detection Algorithms l References
CRM-349608-AB JULY2016
Brief Summary: EMBLEMTM MRI S-ICD
Indications for UseTheS-ICDSystemisintendedtoprovidedefibrillationtherapyforthetreatmentoflife-threateningventriculartachyarrhythmiasinpatientswhodonothavesymptomaticbradycardia,incessant ventricular tachycardia, or spontaneous, frequently recurring ventricular tachycardia thatisreliablyterminatedwithanti-tachycardiapacing.
ContraindicationsUnipolarpacingandimpedance-basedfeaturesarecontraindicatedforusewiththeS-ICDSystem.
WarningsRead the manual thoroughly before using the S-ICD System to avoid damage to the pulse generatorand/orsubcutaneouselectrode.Suchdamagecanresultinpatientinjuryordeath.Forsinglepatientuseonly.Donotreuse,reprocess,orresterilize.AllBostonScientificS-ICDimplantablecomponentsaredesignedforusewiththeBostonScientificS-ICDSystemonly.ConnectionofanyS-ICDSystemcomponentstoanon-compatiblecomponentwillresultinfailuretodeliverlife-savingdefibrillationtherapy.AlwayshaveexternaldefibrillationequipmentandmedicalpersonnelskilledinCPRavailableduringimplantandfollow-uptesting.Usingmultiple pulse generators could cause pulse generator interaction resulting in patient injury or alackoftherapydelivery.Testeachsystemindividuallyandincombinationtohelppreventundesirableinteractions.ConcomitantuseoftheS-ICDSystemandimplantedelectromechanicaldevices (for example a ventricular assist device, VAD; or implantable insulin pump or drug pump) can result in interactions that could compromise the function of the S-ICD, the co-implanteddevice,orboth.Electromagnetic(EMI)ortherapydeliveryfromtheco-implanteddevicecaninterferewithS-ICDsensingand/orrateassessment,resultingininappropriatetherapyorfailuretodelivertherapywhenneeded.Inaddition,ashockfromtheS-ICDpulsegeneratorcoulddamagetheco-implanteddeviceandcompromiseitsfunctionality.Tohelppreventundesirableinteractions,testtheS-ICDsystemwhenusedincombinationwiththeco-implanteddevice,andconsiderthepotentialeffectofashockontheco-implanteddevice.HandlethecomponentsoftheS-ICDSystemwithcareatalltimesandmaintainpropersteriletechnique.Donotmodify,cut,kink,crush,stretchorotherwisedamageanycomponentoftheS-ICDSystem.Usecautionhandlingthesubcutaneouselectrodeconnector.Donotdirectlycontacttheconnectorwithanysurgicalinstrumentssuchasforceps,hemostats,orclamps.Use appropriate anchoring techniques as described in the implant procedure to prevent S-ICD Systemdislodgementand/ormigration.DonotimplantinMRIsiteZoneIII.Usecautionwhenplacing a magnet over the S-ICD pulse generator because it suspends arrhythmia detection and therapyresponse.Inpatientswithadeepimplantplacement(greaterdistancebetweenthemagnetandthepulsegenerator)magnetapplicationmayfailtoelicitthemagnetresponse.DonotexposeapatientwithanimplantedS-ICDSystemtodiathermy.EMBLEMS-ICDdevicesareconsideredMRConditional.UnlessallMRIConditionsofUsearemet,MRIscanningofthepatientdoesnotmeetMRConditionalrequirementsfortheimplantedsystem.TheProgrammerisMRUnsafeandmustremainoutsidetheMRIsiteZoneIII.DuringMRIProtectionModetheTachycardiatherapyissuspended.MRIscanningafterERIstatushasbeenreachmayleadtoprematurebatterdepletion,ashorteneddevicereplacementwindow,orsuddenlossoftherapy.TheBeepermaynolongerbeusablefollowinganMRIscan.ItisstronglyrecommendedthatpatientsarefollowedonLATITUDENXTafteranMRIscaniftheyarenotalready.Advisepatients to seek medical guidance before entering environments that could adversely affect the operationoftheactiveimplantablemedicaldevice,includingareasprotectedbyawarningnoticethatpreventsentrybypatientswhohaveapulsegenerator.Thepulsegeneratormaybemoresusceptibletolowfrequencyelectromagneticinterferenceatinducedsignalsgreaterthan80uV.TheS-ICDSystemhasnotbeenevaluatedforpediatricuse.
CRM-349608-AB JULY2016
Brief Summary: EMBLEMTM MRI S-ICD
PrecautionsForspecificinformationonprecautions,refertothefollowingsectionsoftheproductlabeling: clinical considerations, sterilization and storage, implantation, device programming, environmental and medical therapy hazards, hospital and medical environments, home andoccupationalenvironments,follow-uptesting,explantanddisposalandsupplementalprecautionaryinformation.
Advise patients to avoid sources of EMI because EMI may cause the pulse generator to deliver inappropriatetherapyorinhibitappropriatetherapy.
Potential Adverse Events Potential adverse events related to implantation of the S-ICD System may include, but are not limitedto,thefollowing:Acceleration/inductionofatrialorventriculararrhythmia,adversereaction to induction testing, allergic/adverse reaction to system or medication, bleeding, conductor fracture, cyst formation, death, delayed therapy delivery, discomfort or prolonged healing of incision, electrode deformation and/or breakage, electrode insulation failure, erosion/extrusion, failure to deliver therapy, fever, hematoma/seroma, hemothorax, improper electrodeconnectiontothedevice,inabilitytocommunicatewiththedevice,inabilitytodefibrillateorpace,inappropriatepostshockpacing,inappropriateshockdelivery,infection,keloid formation, migration or dislodgement, muscle/nerve stimulation, nerve damage, pneumothorax, post-shock/post-pace discomfort, premature battery depletion, random component failures, stroke, subcutaneous emphysema, surgical revision or replacement of the system,syncope,tissueredness,irritation,numbnessornecrosis.
PatientswhoreceiveanS-ICDSystemmaydeveloppsychologicaldisordersthatinclude,butarenotlimitedto,thefollowing:depression/anxiety,fearofdevicemalfunction,fearofshocks,phantomshocks.
ForalistofallpotentialadverseeventsassociatedwithMRIscanning,refertotheMRITechnicalGuide. Refer to the product labeling for specific indications, contraindications, warnings/precautions and adverse events. Rx only. (Rev A)